Real World Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

被引：0
|
作者：
Varga, Gergely
Nagy, Zsolt
Kosztolanyi, Szabolcs
Szomor, Arpad
Schneider, Tamas
Deak, Beata
Wolf, Krisztina
Plander, Mark
Szendrei, Tamas
Varoczy, Laszlo
Illes, Arpad
Batai, Arpad
Peto, Monika
Fabian, Janos
Masszi, Tamas
Mikala, Gabor
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1865
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program
    Varga, Gergely
    Nagy, Zsolt
    Demeter, Judit
    Kosztolanyi, Szabolcs
    Szomor, Arpad
    Alizadeh, Hussain
    Deak, Beata
    Schneider, Tamas
    Plander, Mark
    Szendrei, Tamas
    Varoczy, Laszlo
    Illes, Arpad
    Batai, Arpad
    Peto, Monika
    Mikala, Gabor
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (04) : 1615 - 1620
  • [2] "REAL WORLD" DATA ON THE EFFICACY AND SAFETY OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A STUDY OF THE GREEK MYELOMA STUDY GROUP
    Terpos, E.
    Katodritou, E.
    Kotsopoulou, M.
    Ntanasis-Stathopoulos, I.
    Lampropoulou, P.
    Papadaki, S.
    Papathanasiou, M.
    Stoumbos, D.
    Gavriatopoulou, M.
    Repousis, P.
    Kastritis, E.
    Dimopoulos, M. A.
    HAEMATOLOGICA, 2017, 102 : 511 - 512
  • [3] "Real World" Data on the Efficacy and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed / Refractory Multiple Myeloma: A Combined Study from the Greek, Czech and UK Databases
    Terpos, Evangelos
    Maouche, Nadjoua
    Minarik, Jiri
    Katodritou, Eirini
    Jenner, Matthew W.
    Plonkova, Hana
    Gavriatopoulou, Maria
    Vallance, Grant
    Pika, Tomas
    Kotsopoulou, Maria
    Kothari, Jaimal
    Jelinek, Tomas
    Kastritis, Eftathios
    Aitchison, Robin
    Dimopoulos, Meletios A.
    Ramasamy, Karthik
    Hajek, Roman
    BLOOD, 2017, 130
  • [4] REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA
    Ziff, M.
    Cheesman, S.
    Kyriakou, C.
    Mehta, A.
    Papanikolaou, X.
    Rabin, N.
    Wechalekar, A.
    Yong, K.
    Popat, R.
    HAEMATOLOGICA, 2017, 102 : 786 - 787
  • [5] Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
    Terpos, Evangelos
    Ramasamy, Karthik
    Maouche, Nadjoua
    Minarik, Jiri
    Ntanasis-Stathopoulos, Ioannis
    Katodritou, Eirini
    Jenner, Matthew W.
    Plonkova, Hana
    Gavriatopoulou, Maria
    Vallance, Grant D.
    Pika, Tomas
    Kotsopoulou, Maria
    Kothari, Jaimal
    Jelinek, Tomas
    Kastritis, Efstathios
    Aitchison, Robin
    Dimopoulos, Meletios A.
    Zomas, Athanasios
    Hajek, Roman
    ANNALS OF HEMATOLOGY, 2020, 99 (05) : 1049 - 1061
  • [6] Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
    Evangelos Terpos
    Karthik Ramasamy
    Nadjoua Maouche
    Jiri Minarik
    Ioannis Ntanasis-Stathopoulos
    Eirini Katodritou
    Matthew W. Jenner
    Hana Plonkova
    Maria Gavriatopoulou
    Grant D. Vallance
    Tomas Pika
    Maria Kotsopoulou
    Jaimal Kothari
    Tomas Jelinek
    Efstathios Kastritis
    Robin Aitchison
    Meletios A. Dimopoulos
    Athanasios Zomas
    Roman Hajek
    Annals of Hematology, 2020, 99 : 1049 - 1061
  • [7] Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma
    Minarik, Jiri
    Pika, Tomas
    Radocha, Jakub
    Jungova, Alexandra
    Straub, Jan
    Jelinek, Tomas
    Pour, Ludek
    Pavlicek, Petr
    Mistrik, Martin
    Brozova, Lucie
    Krhovska, Petra
    Machalkova, Katerina
    Jindra, Pavel
    Spicka, Ivan
    Plonkova, Hana
    Stork, Martin
    Bacovsky, Jaroslav
    Capkova, Lenka
    Sykora, Michal
    Kessler, Petr
    Stejskal, Lukas
    Heindorfer, Adriana
    Ullrychova, Jana
    Maisnar, Vladimir
    Hajek, Roman
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E271 - E272
  • [8] Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma
    Sokol, Juraj
    Guman, Tomas
    Chudej, Juraj
    Hlebaskova, Monika
    Stecova, Natalia
    Valekova, Lubica
    Kucerikova, Monika
    Stasko, Jan
    ANNALS OF HEMATOLOGY, 2022, 101 (01) : 81 - 89
  • [9] Ixazomib, lenalidomide, and dexamethasone combination in “real-world” clinical practice in patients with relapsed/refractory multiple myeloma
    Juraj Sokol
    Tomas Guman
    Juraj Chudej
    Monika Hlebaskova
    Natalia Stecova
    Lubica Valekova
    Monika Kucerikova
    Jan Stasko
    Annals of Hematology, 2022, 101 : 81 - 89
  • [10] Real World Use of Ixazomib With Lenalidomide and Dexamethasone for Patients With Relapsed Multiple Myeloma
    Lawson, Gabrielle
    Ziff, Monica
    De-Silva, Dunnya
    Cheesman, Simon
    Kyriakou, Charalampia
    Mehta, Atul
    Mahmood, Shameem
    Papanikolaou, Xenofon
    Rabin, Neil
    Sachchithanantham, Sajitha
    Sive, Jonathan
    Wechalekar, Ashutosh
    Yong, Kwee
    Popat, Rakesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E264 - E264
12345